FOR IMMEDIATE RELEASE
Norlase Appoints Andrew Berkowitz Vice President of Global Sales
Ballerup, Denmark and Redwood City, CA, USA – October 13, 2019 – Norlase is excited to announce that it has appointed Andrew Berkowitz to the position of Vice President of Global Sales. Mr. Berkowitz brings over thirty years of ophthalmic device experience to Norlase, having previously held national and global sales positions at successful ophthalmic companies, including laser manufacturers IRIDEX, Optimedica and Topcon. He will be responsible for growing global sales of Norlase’s innovative laser technologies, including the recently launched LEAF green laser photocoagulator.
“Norlase is committed to building a leadership team that deeply understands the products we offer our customers,” said Oliver Hvidt, Norlase Chief Executive Officer. “Andrew was instrumental in the commercial expansion of therapeutic laser technologies within the industry. His technical knowledge, positive relationship with thought leaders and reputation make him a natural choice to lead our sales team and to help guide our future product development.”
Prior to joining Norlase, Mr. Berkowitz spent over 30 years in ophthalmic sales, helping bring over 32 products to market. Products Mr. Berkowitz sold include the first solid-state ophthalmic photocoagulator and first pattern scanning ophthalmic photocoagulator. Andrew recently held a National position at Alcon.
“I’ve been fortunate enough to help launch several laser technologies over the course of my career,” commented Andrew Berkowitz, Norlase Vice President of Global Sales. “Joining the Norlase team gives me an opportunity to offer next generation technology with the introduction of Norlase’s game changing LEAF solid state laser system.
Norlase develops next-generation laser solutions for the treatment of retina and glaucoma disease. Founded in Denmark, Norlase is comprised of worldwide industry experts in ophthalmology, laser technology, medical device development and customer care. Norlase is on a mission to improve practice efficiency, patient care and physician convenience for ophthalmologists worldwide. Norlase entered the United States ophthalmic market with LEAF, a new laser photocoagulator that’s 10X smaller than existing systems and mounts directly on the slit-lamp.
*Norlase LEAF is available for distribution in the US.